Focuses on developing both novel low development risk product candidates and technologies with longer-term major product opportunities.

Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and formulations of existing drugs using its proprietary porous microparticle technology in the United States. Its porous microparticle technology enables to control the size and porosity of particles, including nanoparticles and.. Read More

Adolor Corporation engages in the discovery, development, and commercialization of prescription pain management products primarily in the United States. The company’s lead product candidates include Entereg, which is a small molecule, mu-opioid receptor antagonist designed to block the unwanted effects of opioid.. Read More

Advanced Biotherapy, Inc. does not have significant operations. It focuses on the evaluation of possible acquisition candidates; and acquiring control or non-control position in one or more revenue generating companies or development stage companies, through investment in equity or convertible debt, or an asset.. Read More

Advanced Viral Research Corp., a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions in the United States. Its products include AVR118, a cytoprotective drug composed of a complex.. Read More

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops various therapeutic agents based on its proprietary small molecule catalytic antioxidant compounds for diseases and disorders of the central nervous system, respiratory system, autoimmune system and oncology. It primarily focuses on the.. Read More

Akesis Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of Type 2 diabetes. Its products include AKP-020, a vanadium-based monotherapy that is in Phase IIa clinical trial for the treatment for Type 2 diabetes... Read More

Alexion Pharmaceuticals, Inc., a biotechnology company, develops and delivers life-changing drug therapies for patients with serious and life-threatening medical conditions. It primarily engages in the discovery, development, and commercialization of biologic therapeutic products for the treatment of severe.. Read More

Alexza Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products for the treatment of acute and intermittent conditions primarily in the United States. Its technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows.. Read More

Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other.. Read More

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule therapeutics for the treatment of cancer. Its lead product candidate, PDX (pralatrexate), is a novel antifolate under evaluation in a pivotal Phase 2 trial in patients with relapsed or.. Read More

Alpharma, Inc. develops, manufactures, and markets pharmaceutical products for humans and animals worldwide. The company’s Pharmaceuticals segment markets branded pharmaceutical prescription product, which includes pain medication products sold under the trademark of KADIAN; and a prescription topical.. Read More

A pharmaceutical company, engaged in the research and development of innovative therapeutic products using advanced drug delivery technologies.

ALTANA Aktiengesellschaft engages in the development, manufacture, and marketing of chemical products for various applications worldwide. It provides special products for coatings manufacturers, coatings and plastics processors, and the electronics industry. The company’s product range includes additives,.. Read More

Amarin Corporation plc, a biopharmaceutical company, engages in the research, development, and commercialization of drugs for patients suffering from central nervous system (CNS) and cardiovascular diseases. The company’s CNS development pipeline includes AMR101, a semi-synthetic and highly purified derivative of.. Read More

Amersin Life Sciences Corporation does not have significant operations. Previously, the company, through its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co., Ltd., engaged in the manufacture and commercialization of pain management and generic pharmaceutical products in the People’s Republic of China. The.. Read More

Angiotech Pharmaceuticals, Inc. provides technologies and medical products for local diseases and complications associated with medical device implants, surgical interventions, and acute injury in the United States and internationally. Its Pharmaceutical Technologies segment provides technologies that improve the.. Read More

Ardea Biosciences, Inc., a biotechnology company, engages in the discovery and development of small-molecule therapeutics for the treatment of HIV, cancer, and inflammatory diseases in the United States. Its product portfolio comprises RDEA806, which is in Phase 2a clinical trials for the treatment of HIV and is.. Read More

Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of oral drugs for cardiovascular, central nervous system, inflammatory, and metabolic diseases. Its advanced drug candidate, lorcaserin, is being investigated in a Phase III.. Read More

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics. Its clinical-stage testing products include ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an intravenously administered novel activator of the cell's.. Read More

ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of product candidates designed to eliminate known safety issues associated with commercial drugs using its RetroMetabolic Drug Design technology. The company’s products in Phase II clinical trials include ATI-7505 for the.. Read More

Astralis, Ltd. does not have significant operations. Previously, it was engaged in the research and development of treatments for immune system disorders and skin diseases, such as psoriasis, and psoriatic and rheumatoid arthritis. The company was founded in 1999 and is based in Fairfield, New Jersey.

Atherogenics Inc., a research-based pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of chronic inflammatory diseases, including diabetes and coronary heart disease. The company’s V-Protectant technology based products include AGI-1067, a phase III.. Read More

Avanir Pharmaceuticals, a pharmaceutical company, focuses on developing, acquiring, and commercializing therapeutic products for the treatment of chronic diseases. Its products and product candidates address therapeutic markets, including the central nervous system, inflammation, and infectious diseases. The.. Read More

AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products based on NeuGene antisense drugs and ESPRIT alternative RNA splicing technology. Its lead product candidate, Resten-NG that completed Phase II clinical trial is targeted at cardiovascular disease. The company’s development products.. Read More

Bayer AG offers pharmaceuticals and health care products, agricultural products, and polymers. It operates in three groups: HealthCare, CropScience, and MaterialScience. The HealthCare group engages in the development, production, and marketing of prescription pharmaceuticals, such as for the treatment of.. Read More

Biodel, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of treatments for endocrine disorders, such as diabetes and osteoporosis. The company develops its product candidates by utilizing its proprietary VIAdel technology. It has two insulin product.. Read More

Bio-Warm Corporation, through its wholly owned subsidiary, Mirae Tech Company, Ltd., engages in the manufacture and marketing of far infrared conductive textile products in Japan, the People’s Republic of China, and Europe. It produces plane heater heating mat, heating panel, heating wall paper, heating floor,.. Read More

Cardiome Pharma Corp., through its subsidiaries, operates as a life sciences company that focuses on developing drugs to treat or prevent cardiovascular diseases. The company’s lead product includes Vernakalant (iv), a product candidate designed for the treatment of atrial fibrillation following cardiac surgery... Read More

Cephalon, Inc., a biopharmaceutical company, engages in the discovery, development, and marketing of products to treat human diseases in the United States and internationally. The company primarily focuses on four therapeutic areas: central nervous system disorders, pain, oncology, and addiction. Its products for.. Read More

Chattem, Inc., together with its subsidiaries, engages in the manufacture and marketing of a portfolio of over-the-counter (OTC) healthcare products, toiletries, and dietary supplements. The company markets its products under various brand names in categories, such as medicated skin care, topical pain care, oral.. Read More

The Company is now a holding company whose business is carried out entirely by Shandong Spring Pharmaceutical Co., Ltd., which is engaged in distributing health and beauty aides as well as toiletries.

Cortex Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurodegenerative, and other neurological and psychiatric disorders. The company develops AMPAKINE compounds for the treatment of attention deficit hyperactivity disorder, respiratory.. Read More

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products that address medical needs in the acute care environment in the Untied States, the European Union, Argentina, Canada, India, Israel, Korea, and Taiwan. The company.. Read More

Carrington Laboratories, Inc. operates as a research-based biopharmaceutical, medical device, raw materials, and nutraceutical company. It engages in the development, manufacture, and marketing of naturally-derived complex carbohydrates and other natural product therapeutics for the treatment of major illnesses,.. Read More

Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. The company’s product line comprises GLUMETZA for the treatment of type ii diabetes; ProQuin XR for uncomplicated urinary tract.. Read More

DOV Pharmaceutical, Inc., a biopharmaceutical company, engages in the discovery, in-licensing, and development of novel drug candidates for central nervous system disorders. Its product candidate include DOV 21,947, a triple reuptake inhibitor, which is in Phase II clinical trials for depression, as well as in.. Read More

Dr. Reddy’s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. The company focuses on formulations, active pharmaceutical ingredients and intermediates, generic drugs, critical care products, biotechnology products, custom pharmaceutical services, and drug discovery. It.. Read More

Durect Corporation, a specialty pharmaceutical company, engages in developing pharmaceutical products based on proprietary drug delivery technology platforms. Its products under Phase II clinical trials include POSIDUR, a release injectable to deliver bupivacaine, an off-patent anesthetic agent;.. Read More

DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand.. Read More

Dynavax Technologies Corporation, a biopharmaceutical company, discovers, develops, and commercializes Toll-like Receptor 9 (TLR9) agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases using proprietary approaches that alter immune system responses.. Read More

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, and license of orally administered controlled release drug delivery systems and products in the United States. It offers two daily allergy products, Lodrane 24 and Lodrane 24D. The company also.. Read More

Endo Pharmaceuticals Holdings, Inc. engages in the research, development, sale, and marketing of branded and generic prescription pharmaceuticals for treating and managing pain. Its products include Lidoderm, a topical patch to relieve the pain of postherpetic neuralgia; Percocet and Percodan tablets; Frova.. Read More

Entropin, Inc. ceased its operations in May 2005. Prior to 2005, the company engaged in the research and development of pharmaceutical products, primarily including its proprietary compound ENT-103 for pain therapy. The company was founded in 1984 and is based in Bradenton, Florida.

Forest Laboratories, Inc., together with its subsidiaries, develops, manufactures, and sells branded and generic forms of ethical drug products, and non-prescription pharmaceutical products. Its products include Lexapro, a single isomer version of citalopram HBr for the treatment of depression and generalized.. Read More

Gentium S.p.A., a biopharmaceutical company, engages in the research, development, and manufacture of drugs to treat and prevent various vascular diseases and conditions related to cancer and cancer treatments. Its lead product candidate includes defibrotide, a DNA based drug derived from pig intestines, to treat.. Read More

Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. The company develops a range of anti-cancer therapies, including anti-cancer therapies based on telomerase.. Read More

The Company deals in formulating, blending, encapsulating and packing nutritional supplements.

Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing prescription pharmaceutical products for diseases in the ophthalmic and respiratory/allergy areas. The company offers AzaSite, an azithromycin ophthalmic solution and topical anti-infective;.. Read More